The evolution of genome editing technology based on CRISPR (clustered regularly interspaced short palindromic repeats) system has led to a paradigm shift in biological research. CRISPR/Cas9-guide RNA complexes enable rapid and efficient genome editing in mammalian cells. This system induces double-stranded DNA breaks (DSBs) at target sites and most DNA breakages induce mutations as small insertions or deletions (indels) by non-homologous end joining (NHEJ) repair pathway. However, for more precise correction as knock-in or replacement of DNA base pairs, using the homology-directed repair (HDR) pathway is essential. Until now, many trials have greatly enhanced knock-in or substitution efficiency by increasing HDR efficiency, or newly developed methods such as Base Editors (BEs). However, accuracy remains unsatisfactory. In this review, we summarize studies to overcome the limitations of HDR using the CRISPR system and discuss future direction. [BMB Reports 2019; 52(8): [475][476][477][478][479][480][481] 
INTRODUCTION
Genetically engineered mice are valuable subjects for developmental and pathomechanism studies. However, the traditional gene targeting method through embryonic stem cells (ESCs) has been time-consuming and costly. In 2013, the Jaenisch group introduced conducting gene modified mice in a one-step generation using clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 (Cas9) genome engineering technology (1, 2) . Since the CRISPR/Cas9-mediated system originated from the prokaryotic immune system (3) (4) (5) (6) , it enabled rapid and efficient genome editing in mammalian cells (7) (8) (9) (10) (11) .
This system opened a new era in genome biology fields including animal, plants, and human genetic disease (12) (13) (14) (15) . Programmable endonuclease Cas9 with guide RNA (gRNA) induce DNA double-strand breaks (DSBs) on the target DNA sequences, and DSBs are repaired by non-homologous endjoining (NHEJ) or homology-directed repair (HDR) pathway, mainly (16) (17) (18) . Among them, NHEJ is a predominant repair mechanism in higher eukaryotic cells or organisms. Therefore, after DSBs, NHEJ works dominantly and generates small insertions or deletions (indels), resulting in frame shifts at target genes eventually (19) (20) (21) . Taking advantage of these characteristics, the efficient knock-out study through NHEJ pathway has been developed extensively in the genome editing field. However, since the NHEJ repair mechanism induces uncontrollable random mutations on target loci, NHEJ conjugated technologies showed limitations for precise genome editing, such as designated insertions and single-nucleotide substitutions (2, 22) .
To overcome these limitations, many scientists made an effort to develop methods to insert donor template DNA using the HDR pathway, to perform precise gene editing. However, it was difficult to use HDR mechanism in gene editing unrestricted because of its extremely low efficiency. In mammalian cells, NHEJ is the major source of the DNA repair mechanism competing with the HDR pathway. Therefore, for more efficient HDR-mediated precise genome editing, numerous researchers have attempted to enhance HDR pathway or/and suppress NHEJ pathway by targeting key factors (23) (24) (25) .
Recently, a new technology called base editors (BEs) has been introduced to overcome low accuracy of NHEJ and low efficiency of HDR. These powerful editing tools can change single nucleotide without DNA DSBs in cells (26, 27) . BEs are composed of catalytically impaired Cas9 variant with deaminase classified as cytosine base editors (CBEs) and adenine base editors (ABEs), allowing direct conversion from C to T or A to G (28) (29) (30) . Recent reports showed that various applications using base editors enable single nucleotide substitutions in mammalian genome successfully (31) (32) (33) (34) (35) In this review, we will report recently developed methods for precise gene editing as enhanced HDR-mediated gene engineering and direct base editing in mammal species. Diverse strategies to increase HDR efficiency are introduced. One is optimization of the HDR pathway by controlling the length of homology arms of template donor DNA. Another is the inhibition of NHEJ pathway which competes with HDR. Additionally, we also introduce BEs, a method for tailored single nucleotide substitution.
ENHANCING KNOCK-IN EFFICACY BY CONTROLLING DONOR DNA
The most precise genome editing method is utilizing HDR mechanism to insert artificial DNA sequences to target locus or to induce single-nucleotide substitutions. However, the efficiency of HDR pathway in nature is extremely low (2, (36) (37) (38) . Recently, several studies reported new methods to overcome low efficiency by optimizing template donor DNA. Researchers modulated the length of homology arms and types of donor DNA, such as single strand DNA (ssDNA) or double strand DNA (dsDNA) ( 
ENHANCING KNOCK-IN EFFICIENCY BY SMALL MOLECULES
NHEJ mediated genome editing induces random mutations such as small indels on target sites. Therefore, these kinds of mutations led the frame shift on targeted genes and is proper for knock-out studies but not for inducing precise mutations, such as point mutations or knock-in studies. Conversely, HDR repair system is good in generating precise point mutations and for inserting external artificial DNA sequences. However, low efficiency has always been a major obstacle to broad use. A number of studies have attempted to increase HDR efficiency by regulating DSBs repair mechanisms (Fig. 1A) . It is well known that NHEJ and HDR pathways are in competition (49) (50) (51) . Several studies have shown that suppression of key molecules involved in the NHEJ pathway could increase efficiency of HDR. Many proteins are known to be relevant with NHEJ pathway including Ku heterodimers (Ku70/80), DNA-dependent protein kinase catalytic subunits (DNA-PKcs), DNA ligase IV, the X-ray repair cross-complementing protein 4 (XRCC4), and the XRCC4-like factor (XLF) as core complexes (52) (53) (54) (58) . Major DNA repair pathways, NHEJ and HDR are not always activated during all cell cycle stages. NHEJ dominates over all M, G1, S, and G2 phases, while HDR can only compete with NHEJ, during S and G2 phases. HDR is down regulated during M phase and G1 phase (59) (60) (61) . Various small molecules exert their effects by controlling such stages in part (Fig. 1B) . Li et al. re-tested the function of Scr7 and L755505, in porcine fetal fibroblast. Additionally, resveratrol, a novel small molecule in this field was also tested. Scr7 and L755505 in porcine fetal fibroblast led a 2-fold increase similar as tested in other cell lines, and the resveratrol could raise approximately 3-fold in porcine fetal fibroblast. It is also reported that L755505 and resveratrol could arrest cells at S phage, wherein the HDR mechanism is activated. Treatment of three molecules such as Scr7, L755505, and resveratrol, up-regulated mRNA expression level of HDR key factors, such as BRCA1, BRCA2, RPA3, SPIDR, NBN, RAD50, RAD51, and RAD52, and down-regulated key molecules of NHEJ pathway such as LIG4, MRE11, DCLRE1C, and XRCC4 (62) . Also, multiple researchers identified small molecules that affect cell cycle arrest to increase HDR. Nocodazole and Lovastatin synchronize the cell cycle in G2/M phase and early G1 phase, respectively. Lovastatin also inhibits at G2/M phase, partially. Mimosine, aphidicolin, thymidine, and hydroxyurea arrest cells at between G1 phase and S phase, before DNA replication (61, 63) . Recently, Canny et al. regulated another key factor: 53BP1. It is significant at the beginning of the repair mechanism between NHEJ and HDR pathways on the DSBs loci. The 53BP1 blocks DNA end resection and recruitment of BRCA1 to DSBs. This study has shown that the 53BP1 inhibitor, i53, can increase HDR efficiency (64). Song et al. reported applying RS-1 could increase HDR efficiency by stimulating Rad51. Unlike previously reported studies, in which small molecules were used to inhibit the NHEJ pathway, this study used a small molecule, RS-1, to promote the HDR pathway (65) . Most of the cases of treatment of small molecules are focused on suppression of NHEJ pathways since both repair mechanisms are in competition.
NUCLEOTIDE REPLACEMENT WITH BASE EDITORS
More than 50% of human pathogenic mutations are point mutations or single nucleotide polymorphisms (SNPs) (26) . As the importance of precise medicine arises, accurate single nucleotide substitutions in the genome have been required for pathology or mechanistic studies. However, in the beginning of the CRISPR technology, specific nucleotide substitutions at desired target sites could only be induced by an HDR-based CRISPR system, despite its low efficiency. To overcome such limitation, new tools called Base Editors (BEs) were developed to induce single-nucleotide substitution, which do not need a template donor DNA ( Fig. 2A and 2B ) (28) (29) (30) . Because these techniques do not introduce DSBs, they never use DNA repair http://bmbreports.org BMB Reports mechanisms as NHEJ, MMEJ, or HDR pathways. BEs were composed of nuclease activity deficient Cas9, nickase Cas9 (nCas9) or dead Cas9 (dCas9), and cytidine deaminase or adenine deaminase. They enable conversion of C to T, or A to G, and vice versa. They are newly-developed methods not affected by HDR efficiency in case of inducing substitutions. These tools were verified through various research groups and applied to many other organisms, including mice and rabbits (31, 32, 66, 67) . The substitution efficiency was higher than the HDR mechanism. However, the unique characteristic of BEs, such as base editing window which indicates the specific region occurring substitution, could be a limitation to inducing single-nucleotide substitution to the exact target base pair. So, some researchers attempted to change the base editing window. One study induced some mutations at cytidine deaminase domains to narrow the base editing window for more specific substitutions (68) . Conversely, to extend coverage of BE systems, some researchers demonstrated that using the extended guided RNA could extend coverage of BEs and using Cas9 variants with different protospacer adjacent motif (PAM) sequences, such as xCas9 and VQR variants (32, 69, 70) . There remain several improvements in the BE system. Accuracy and efficacy have not been satisfied for clinical demands and knock-in of external DNA sequences are impossible.
CONCLUSION
CRISPR/Cas9 mediated genome engineering applicable to a variety of organisms is crucial as a tool for research and clinical applications. In this review, we showed efforts to increase efficiency of HDR, one of the genetic manipulation strategies, for accurate and specific targeted knock-in. Recent efforts to improve HDR efficiency have focused on controlling the homology arm length, or suppressing the NHEJ pathway using small molecules. In particular, the Tild-CRISPR method, a method of controlling donor DNA homology arm length, is expected to greatly improve the efficiency of HDR. Based on these results, HDR efficiency is expected to be enhanced by combining NHEJ pathway inhibition with small molecules and the control of homology arm length. Additionally, the BEs (nucleotide substitution methods for specific target sites) are expected to be applied to studies of clinical pathology mechanism by allowing tailored point mutation. Recently, development of gene editing technology has suggested the possibility of clinical application as a genetic disease therapeutic agent. However, accuracy of gene correction fails to meet clinical demands and additionally, the stable in vivo delivery system is lacking. To overcome these problems and to apply clinical applications for therapeutic purposes, it is necessary to improve gene editing accuracy/efficiency and develop in vivo delivery systems delivery systems, simultaneously.
